McNicoll Lewis & Vlak Raises PT on AMAG Pharmaceuticals to $23

McNicoll Lewis & Vlak has raised the price target on AMAG Pharmaceuticals AMAG to $23 and maintains its Buy rating.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Price TargetIntraday UpdateAnalyst Ratingsmcnicoll lewis vlak
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!